Esther Napolitano, BS

Freelance Science Writer

Recent Blog Posts

Pictured: Oliver Zivanovic, Garrett Nash & Dennis Chi
In the Clinic
Friday, November 15, 2013

Memorial Sloan Kettering experts are leading investigations of a procedure called hyperthermic intraperitoneal chemotherapy, also known as HIPEC.

Pictured: Michael Zelefsky
In the Clinic
Wednesday, October 23, 2013

Memorial Sloan Kettering offers patients with prostate cancer a comprehensive package of the most advanced radiation therapy approaches that enable more-personalized and effective care.

In the Community
Thursday, October 10, 2013

Memorial Sloan Kettering leads a first-of-its-kind initiative to reduce cancer and cardiovascular health disparities among South Asian immigrants in the United States.

Pictured: Joanne Frankel Kelvin, Nadeem  Abu-Rustum & Larissa Temple
Video
Monday, September 16, 2013

Memorial Sloan Kettering experts discuss the impact that cancer and its treatment can have on female fertility, and options for building a family after treatment ends.

Pictured: Micropapillary Morphology
In the Lab
Friday, August 9, 2013

A Memorial Sloan Kettering study shows that an abnormal cell pattern found in the tumor tissue of some lung cancer patients may help to predict which tumors are more likely to recur after surgery.

Pictured: Scott Armstrong, Michael Kuehn, Haijhua Chu, Monica Cusan & Andrei Kritsov
Profile
Friday, July 12, 2013

Scott Armstrong specializes in the treatment of leukemia in children. His research focuses on the disease in children and adults.

Pictured: Christopher Lima
Honor
Thursday, May 9, 2013

Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.

Pictured: Peter Scardino
Q&A
Thursday, March 14, 2013

Dr. Scardino discusses strategies for how physicians and patients can make the best use of PSA testing and prostate cancer treatment.

Pictured: Clifford Hudis
Q&A
Wednesday, December 5, 2012

New, potentially practice-changing research sheds light on the long-term benefits of estrogen-blocking tamoxifen therapy in women with early-stage breast cancer whose disease is estrogen-receptor positive.

Pictured: Harrie Bakst and Duane Bailey-Castro
Event
Thursday, July 5, 2012

More than 2,000 patients and their guests, caregivers, and healthcare providers attended Memorial Sloan Kettering’s cancer survivorship celebrations last month.

Pictured: Robert Motzer
In the Clinic
Monday, May 21, 2012

Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.

Pictured: Elizabeth Morris
In the O.R.
Friday, March 16, 2012

Memorial Sloan Kettering is the first and only hospital in New York, New Jersey, and Connecticut to offer a new, more patient-friendly approach for doctors to precisely pinpoint and remove small breast cancers.

Pictured: Ann Zauber
In the Clinic
Thursday, February 23, 2012

For the first time, a new study has shown that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease.

Pictured: Robert Motzer
In the Clinic
Tuesday, February 7, 2012

The recent FDA approval of axitinib provides a viable treatment option for patients who progress on or cannot tolerate the side effects of other approved drugs for the disease.

Finding
Monday, January 23, 2012

Research has shown that children who have experienced a sunburn at an early age are at almost double the risk for developing melanoma in adulthood. Now, a new study led by Memorial Sloan Kettering epidemiologist Stephen Dusza finds that most children do not regularly use sunscreen.